Clinical trial
Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure
NCT04956809
Study timeline
Study start (actual)2021-10-22Date precision: day
Registry last updated2023-12-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HFrEFunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
University of Pennsylvanialead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04956809 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.